Analyst firms · Morgan Stanley · SNPS

Morgan Stanley SNPS price target and rating history

Synopsys Inc. (SNPS) · Technology

Morgan Stanley rates Synopsys Inc. (SNPS) Overweight with a $500 price target, as of its latest action on Sep 8, 2026. It has published 3 rating actions on SNPS since November 2023, including 1 upgrade and 1 downgrade. Across 10 firms with a SNPS price target in the last 12 months, the median target is $560. Morgan Stanley's $500 is 11% below that.

Current rating
Overweight
Price target
$500
Median target, all firms
$560
Actions on SNPS
3

Morgan Stanley price target on SNPS

$600$540$480202420252026
Morgan Stanley price target on SNPS, each point a stated target, November 2023 to September 2026.

Every Morgan Stanley rating on SNPS

How other firms rate SNPS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
HSBCBuy$700Sep 25, 2026
BNP Paribas ExaneNeutral$420Sep 24, 2026
Wells FargoOverweight$475Sep 10, 2026
Morgan StanleyOverweight$500Sep 8, 2026
Robert W. BairdOutperform$560Aug 27, 2026
The Benchmark CompanyBuy$570Jul 16, 2026
Piper SandlerOverweight$550Jun 23, 2026
BofA SecuritiesBuy$560Dec 11, 2025
RosenblattBuy$560Dec 9, 2025
CitigroupBuy$580Nov 24, 2025

Questions about Morgan Stanley and SNPS

What is Morgan Stanley's price target for SNPS?
Morgan Stanley's latest stated price target for Synopsys Inc. (SNPS) is $500, from its action on Sep 8, 2026.
What is Morgan Stanley's rating on SNPS?
Morgan Stanley rates SNPS Overweight, a bullish rating, as of Sep 8, 2026.
When did Morgan Stanley last change its view on SNPS?
On Sep 8, 2026, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $500.
How does Morgan Stanley's SNPS target compare with other analysts?
Across 10 firms with a SNPS price target in the last 12 months, the median target is $560. Morgan Stanley's $500 is 11% below that.

More SNPS rating histories

All Morgan Stanley ratingsSNPS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.